Screening for Cystic Fibrosis Related Complications in the Context of a Pandemic and Altered Models of Care

Background: Standard of care recommend that patients with cystic fibrosis (CF) require screening investigations to assess for complications. Changing models of care due to the COVID19 pandemic may have impacted completion of recommended screening. Objective: To compare the frequency of screening inv...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael Doumit (Author), Roxanne Strachan (Author), Raynuka Lazarus (Author), Peter Middleton (Author), Ruth Dentice (Author), Jessica Marouvo (Author), Laura Jeffrey (Author), Hiran Selvadurai (Author), Sheila Sivam (Author), Verity Pacey (Author), Adam Jaffe (Author), Kelly Gray (Author)
Format: Book
Published: SAGE Publishing, 2023-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_6e8d6593b3704b7bb8b0e49f37bd53a9
042 |a dc 
100 1 0 |a Michael Doumit  |e author 
700 1 0 |a Roxanne Strachan  |e author 
700 1 0 |a Raynuka Lazarus  |e author 
700 1 0 |a Peter Middleton  |e author 
700 1 0 |a Ruth Dentice  |e author 
700 1 0 |a Jessica Marouvo  |e author 
700 1 0 |a Laura Jeffrey  |e author 
700 1 0 |a Hiran Selvadurai  |e author 
700 1 0 |a Sheila Sivam  |e author 
700 1 0 |a Verity Pacey  |e author 
700 1 0 |a Adam Jaffe  |e author 
700 1 0 |a Kelly Gray  |e author 
245 0 0 |a Screening for Cystic Fibrosis Related Complications in the Context of a Pandemic and Altered Models of Care 
260 |b SAGE Publishing,   |c 2023-10-01T00:00:00Z. 
500 |a 1178-6329 
500 |a 10.1177/11786329231205145 
520 |a Background: Standard of care recommend that patients with cystic fibrosis (CF) require screening investigations to assess for complications. Changing models of care due to the COVID19 pandemic may have impacted completion of recommended screening. Objective: To compare the frequency of screening investigations completed in people with CF before and after the onset of the COVID19 pandemic. Methods: Medical records were reviewed at 4 CF-specialist centers to identify screening investigations completed in the 12-months before and after pandemic onset. Results: Records of 625 patients were reviewed. Prior to pandemic onset, there was between center variability in completion of screening investigations. There was greatest baseline variation between centers in performing oral glucose tolerance test (OGTT); range 38%-69%, exercise tests; 3%-51% and sputum screening for non-tuberculous mycobacteria; 53%-81%. Following pandemic onset, blood tests, and sputum cultures were maintained at the highest rates. Exercise testing, CXR and OGTT exhibited the greatest declines, with reductions at individual centers ranging between 10%-24%, 22%-43%, and 20%-26%, respectively. Return to in-person visits following pandemic onset was variable, ranging from 16% to 74% between centers. Conclusion: Completion of screening investigations varies between CF centers and changes in models of care, such as increased virtual care in response to COVID19 pandemic was associated with reduction in completion of investigations. Centers would benefit from auditing their adherence to standards of care, particularly considering recent changes in care delivery. 
546 |a EN 
690 |a Medicine (General) 
690 |a R5-920 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Health Services Insights, Vol 16 (2023) 
787 0 |n https://doi.org/10.1177/11786329231205145 
787 0 |n https://doaj.org/toc/1178-6329 
856 4 1 |u https://doaj.org/article/6e8d6593b3704b7bb8b0e49f37bd53a9  |z Connect to this object online.